- Home
- CSBR vs KORE Comparison
CSBR vs KORE Comparison
Compare CSBR & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- KORE
- Stock Information
- Founded
- CSBR 1985
- KORE 2003
- Country
- CSBR United States
- KORE United States
- Employees
- CSBR N/A
- KORE N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- KORE Telecommunications Equipment
- Sector
- CSBR Health Care
- KORE Consumer Discretionary
- Exchange
- CSBR Nasdaq
- KORE Nasdaq
- Market Cap
- CSBR 60.6M
- KORE 50.8M
- IPO Year
- CSBR 1986
- KORE N/A
- Fundamental
- Price
- CSBR $5.23
- KORE $2.13
- Analyst Decision
- CSBR Strong Buy
- KORE Buy
- Analyst Count
- CSBR 2
- KORE 4
- Target Price
- CSBR $6.75
- KORE $12.00
- AVG Volume (30 Days)
- CSBR 129.1K
- KORE 10.9K
- Earning Date
- CSBR 09-11-2024
- KORE 11-07-2024
- Dividend Yield
- CSBR N/A
- KORE N/A
- EPS Growth
- CSBR N/A
- KORE N/A
- EPS
- CSBR N/A
- KORE N/A
- Revenue
- CSBR $51,655,000.00
- KORE $284,942,000.00
- Revenue This Year
- CSBR $9.14
- KORE $3.55
- Revenue Next Year
- CSBR $10.03
- KORE $5.72
- P/E Ratio
- CSBR N/A
- KORE N/A
- Revenue Growth
- CSBR N/A
- KORE 7.91
- 52 Week Low
- CSBR $3.60
- KORE $1.30
- 52 Week High
- CSBR $7.13
- KORE $6.45
- Technical
- Relative Strength Index (RSI)
- CSBR 67.10
- KORE 46.75
- Support Level
- CSBR $3.60
- KORE $2.00
- Resistance Level
- CSBR $5.23
- KORE $2.59
- Average True Range (ATR)
- CSBR 0.35
- KORE 0.20
- MACD
- CSBR 0.10
- KORE -0.01
- Stochastic Oscillator
- CSBR 87.57
- KORE 59.02
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. They derive revenue primarily from research services.
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.